INVESTMENT IN KIDNEY DISEASE PREVENTION, RESEARCH, AND TECHNOLOGY INNOVATION

KIDNEY HEALTH

Bill and Danielle Gottfried, the Founders and Directors of The Kidney Research Institute of Texas, are committed to helping end the global kidney disease pandemic where one-third of the world’s population is at risk for kidney disease. The Kidney Research Institute of Texas was established to be a catalyst to help accelerate investment in kidney disease prevention, kidney disease research, and technology innovation to support kidney patients. Since 2020, Bill and Danielle Gottfried have personally invested over $250,000 to support kidney research.

In this New Year of 2025, Bill and Danielle are committed to accelerating investment in kidney health research and kidney disease prevention. Bill and Danielle are not relying on Federal Government funding. They are focused on health care endowments and health care philanthropic organizations, private sector financial support from organizations interested in kidney health research, international donors, and individuals who have been touched or who have family members and friends who have been touched by kidney disease and kidney failure.

The Kidney Research Institute of Texas was established in memory of family members who suffered from kidney failure, including Bill Gottfried’s Father, Henry William Gottfried, Jr., CDR, U.S. Navy, Submarine Service.

Please continue to visit this web site as we will be providing updates on our activities as we press forward in 2025.

We thank you for and we appreciate your interest in kidney disease research. Kidney research is not an area that garners a lot of attention, unfortunately. However, as mentioned earlier, one-third of the world’s population is at risk for kidney disease.

Unknown's avatar

Published by Bill and Danielle Gottfried, Founders of The Kidney Research Institute of Texas

Bill and Danielle Gottfried established The Kidney Research Institute of Texas in Houston; we are committed to finding the cure for kidney disease. Bill's Father, Henry William Gottfried, Jr., died early in his life from kidney failure and Bill has had other Family members afflicted by kidney disease. Danielle has had Family members suffer from kidney disease and kidney failure. Our goal is to raise investments that will be allocated directly to the leading kidney research and kidney dialysis technology innovation teams in Houston, around the U.S., and worldwide that are conducting leading edge research on finding the cure for kidney disease and improving patient care. Bill Gottfried has been involved in the biotechnology industry since the early 1980's, the dawn of the biotechnology era. He has supported biotechnology and health care investment in the U.S., Europe, and Asia, and he recruited the management team for the first biotechnology company that was established in Houston. Bill has provided capital formation, executive search, and strategic planning expertise to biotechnology industry clients for over 30 years. He was a founding member of BIOHouston and the Biotechnology Industry Organization in Washington, D.C.

Published

Leave a comment